Compound Detail
CHEMBL4788874
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1cccc2c(Nc3ccc4[nH]c(C(=O)N/N=C/c5cc(C(C)(C)C)c(O)c(C(C)(C)C)c5)cc4c3)cc(C)nc12
Basic Information
| ChEMBL ID | CHEMBL4788874 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | KMHLYACZICEBAX-ODNPBWNPSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
577.7
MW (Da)
7.84
ALogP
6
HBA
4
HBD
111.6
PSA (Ų)
0.12
QED
2
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 5.45
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| L02 | IC50 | = | 3540.0 | nM | 5.45 | Cytotoxicity against human L02 cells assessed as reduction in cell viability inc... | 32717483 |
| QGY-7703 | IC50 | = | 4020.0 | nM | 5.4 | Antiproliferative activity against human QGY-7703 cells assessed as reduction in... | 32717483 |
| HepG2 | IC50 | = | 7450.0 | nM | 5.13 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 32717483 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32717483 | 10.1016/j.ejmech.2020.112608 | HepG2 | 1 |
| 32717483 | 10.1016/j.ejmech.2020.112608 | QGY-7703 | 1 |
| 32717483 | 10.1016/j.ejmech.2020.112608 | SMMC-7721 | 1 |
| 32717483 | 10.1016/j.ejmech.2020.112608 | L02 | 1 |
Data from ChEMBL 36 via Core Engine